MADRIGAL PHARMACEUTICALS, INC.
MADRIGAL PHARMACEUTICALS, INC. (MDGL) is a publicly traded company in the Unknown sector. Across all available filings, 29 corporate insiders have executed 717 transactions totaling $865.6M, demonstrating a bearish sentiment with -$583.5M in net insider flow. The most recent transaction on Jan 26, 2026 involved a transaction of 4,000 shares valued at $0.
MDGL Insider Activity Summary
Who Is Buying MDGL Stock?
No significant insider buying has been recorded for MDGL in the recent period.
Who Is Selling MDGL Stock?
No significant insider selling has been recorded for MDGL in the recent period.
Is MADRIGAL PHARMACEUTICALS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MDGL is bearish with an Insider Alignment Score of 16/100 and a net flow of -$583.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
MDGL Frequently Asked Questions
Understanding MDGL Insider Activity
Insider trading at MADRIGAL PHARMACEUTICALS, INC. (MDGL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 29 insiders are actively trading MDGL stock, having executed 717 transactions in the past 90 days. The most active insider is Fred B. Craves (Executive), who has made 45 transactions totaling $219.4M.
Related Tools
Track MADRIGAL PHARMACEUTICALS, INC. Insider Activity
Get notified when executives and directors at MDGL file new Form 4 transactions